Abernethy, A. P., Arunachalam, A., Burke, T., McKay, C., Cao, X., Sorg, R., & Carbone, D. P. (2017). Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting. Public Library of Science (PLoS).
Chicago Style CitationAbernethy, Amy P., Ashwini Arunachalam, Thomas Burke, Caroline McKay, Xiting Cao, Rachael Sorg, i David P. Carbone. Real-world First-line Treatment and Overall Survival in Non-small Cell Lung Cancer Without Known EGFR Mutations or ALK Rearrangements in US Community Oncology Setting. Public Library of Science (PLoS), 2017.
Cita MLAAbernethy, Amy P., et al. Real-world First-line Treatment and Overall Survival in Non-small Cell Lung Cancer Without Known EGFR Mutations or ALK Rearrangements in US Community Oncology Setting. Public Library of Science (PLoS), 2017.